Mucosolvan Long Effect (Ambroxol Hydrochloride)

Ambroxol stimulates surfactant production by type II pneumocytes and reduces mucus viscosity. It enhances the activity of lysosomal enzymes that break down mucopolysaccharide fibers and improves ciliary motion, which together accelerate the removal of bronchial secretions.

The appropriate dose of Mucosolvan Long Effect is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and overall health status. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for Ambroxol during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Ambroxol is a direct mucolytic that not only reduces mucus viscosity but also stimulates surfactant production, offering a dual mechanism. Compared with agents such as acetylcysteine, Ambroxol tends to have a more pronounced effect on sputum clearance and may be better tolerated with fewer gastrointestinal side effects.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and direct sunlight. Do not store in damp or excessively hot environments, and keep out of reach of children.

Mucosolvan Long Effect is taken orally, usually with a glass of water. The tablet should be swallowed whole unless the prescriber advises otherwise. It can be taken with or without food, but consistent administration as directed helps maintain therapeutic effect.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, hepatotoxicity, blood dyscrasias, angioedema, and bronchospasm. Patients should seek immediate medical attention if they experience symptoms like rash, difficulty breathing, jaundice, or sudden swelling.

Individuals with known hypersensitivity to Ambroxol or any excipients in the tablet should avoid the product. Patients with a history of severe allergic reactions, uncontrolled asthma, or certain hepatic conditions should consult their physician before use.